Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02418208 · ClinicalTrials.gov registry record
Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials
A clinical trial, sponsored by ElMindA.
- Completed
- Registry status
- 964
- Enrollment target
NCT02418208: Completed study, sponsored by ElMindA.
NCT02418208 is a clinical trial that has completed, run by ElMindA. The registered enrollment target is 964 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02418208 has completed, sponsored by ElMindA.
- COMPLETED
- Registry status
- 964 participants
- Enrollment target
Study Summary
Purpose: EEstablish normative data of ElMindA's Brain Network Activation (BNA) using evoked response potentials in adolescents, young adults and Adults. Trial design: Open, one-arm, prospective, age-stratified, multi site. Enrollment size: Up to 1500 subjects will be enrolled in 4 or more sites. Study duration: Each patient will be followed up for up to 1 year. Overall study duration will be up to 1.5 years. Patient population: Adolescents, young adults and Adults of both genders. Age range: * 10-11.99 * 12-13.99 * 14-15.99 * 16-17.99 * 18-24.99 * 25-29.99 * 30-34.99 * 35-39.99 * 40-44.99 * 45-49.99 * 50-54.99 * 55-60 * 60 and above Objective: Establishment of normative data of BNA.
Primary Outcome
Functional networks of brain activity in healthy individuals measured using analysis of EEG Event Related Potential (ERP) data
Interventions
- DIAGNOSTIC_TEST Performint EEG tests and BNA analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 964 participants |
| Start Date | 2015-03 |
| Est. Completion | 2019-11 |
What the finished NCT02418208 record still lists
NCT02418208 is an observational study that tracks outcomes without assigning an intervention. The registered 964 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Performint EEG tests and BNA analysis is the first listed.
NCT02418208 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02418208 about?
NCT02418208 is a clinical study titled "Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials". Purpose: EEstablish normative data of ElMindA's Brain Network Activation (BNA) using evoked response potentials in adolescents, young adults and Adults. Trial design: Open, one-arm, prospective, age-stratified, multi site. Enrollment size: Up to 1500 subjects will be enrolled in 4 or more sites. St...
What is the current status of trial NCT02418208?
This trial is currently completed. The enrollment target is 964 participants. The study started on 2015-03. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02418208?
The interventions under investigation include: Performint EEG tests and BNA analysis (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02418208?
This trial is sponsored by ElMindA, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia